Chan Henry Lee Sells $236K of BeOne Medicines Ltd (ONC) — SEC Form 4, Jun 10, 2026

Open-Market Net Sale · SEC Form 4
−$235,539

Equity position changed by -0.3%

Reporting Owner
TXN 2026-06-08 · FILED 2026-06-10
Equity Position 307K sh 307,918 → 307,047
Equity Change -0.3% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-06-10
Report Date
2026-06-10
Accession No.
0001980648-26-000013
Accepted At
2026-06-10 21:26 UTC
Reporting Owner
Name Relationship
Chan Henry Lee CIK 0001980648
GC
Chan Henry Lee at BeOne Medicines Ltd Full insider history
Bought (12 mo) —
Sold (12 mo) $4,632,539
More from this insider at BeOne Medicines Ltd
2026-10-02 Sell -$418,125 View
2026-08-14 Sell -$959,760 View
2026-08-03 Sell -$337,932 View
2026-07-24 Sell -$542,425 View
2026-07-10 Sell -$200,833 View
All filings by this insider at BeOne Medicines Ltd
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
American Depositary SharesF1F2F3 2026-06-08 S - Sale 711 D $270.24 -$192,138 160 Direct
American Depositary SharesF1F2F4 2026-06-08 S - Sale 160 D $271.26 -$43,401 0 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Ordinary Shares 307,047 Direct
Footnotes (4)
F1
Each American Depositary Share represents 13 Ordinary Shares. Show more
F2
The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Show more
F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.90 to $270.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.00 to $271.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
5%+ Holders · 13D/G 2 filers
Other insiders at BeOne Medicines Ltd
All BeOne Medicines Ltd insider activity
GET /v1/forms/4/0001980648-26-000013 API docs
View Original SEC Filing